Lessons Learned from the COVID-19 Pandemic and How Blood Operators Can Prepare for the Next Pandemic

por Drews, Steven J., O’Brien, Sheila F.
Publicado 2022

An expanded role for blood donor emerging pathogens surveillance

por O’Brien, Sheila F., Goldman, Mindy, Drews, Steven J.
Publicado 2023

SARS-CoV-2 Seroprevalence among Canadian Blood Donors: The Advance of Omicron

por O’Brien, Sheila F., Caffrey, Niamh, Yi, Qi-Long, Pambrun, Chantale, Drews, Steven J.
Publicado 2022

Changing Patterns of SARS-CoV-2 Seroprevalence among Canadian Blood Donors during the Vaccine Era

por Reedman, Cassandra N., Drews, Steven J., Yi, Qi-Long, Pambrun, Chantale, O’Brien, Sheila F.
Publicado 2022

The estimated risk of SARS-CoV- 2 infection via cornea transplant in Canada

por O’Brien, Sheila F., Lewin, Antoine, Yi, Qi-Long, Dowling, Graeme, Fissette, Etienne, Drews, Steven J.
Publicado 2021

Surveillance of Transfusion-Transmissible Infections: Comparison of Systems in Five Developed Countries

por O'Brien, Sheila F., Zou, Shimian, Laperche, Syria, Brant, Lisa J., Seed, Clive R., Kleinman, Steven H.
Publicado 2012

Immunogenicity and safety of mixed COVID-19 vaccine regimens in patients with immune-mediated inflammatory diseases: a single-centre prospective cohort study

por Hitchon, Carol A, Mesa, Christine, Bernstein, Charles N, Marrie, Ruth Ann, Card, Catherine, O’Brien, Sheila F, Kim, John
Publicado 2023

Epidemiology of Hospitalized Patients with Babesiosis, United States, 2010–2016

por Bloch, Evan M., Day, Jonathan R., Krause, Peter J., Kjemtrup, Anne, O’Brien, Sheila F., Tobian, Aaron A.R., Goel, Ruchika
Publicado 2022

SARS-CoV-2 Virus-Like Particle Neutralizing Capacity in Blood Donors Depends on Serological Profile and Donor-Declared SARS-CoV-2 Vaccination History

por Drews, Steven J., Hu, Queenie, Samson, Reuben, Abe, Kento T., Rathod, Bhavisha, Colwill, Karen, Gingras, Anne-Claude, Yi, Qi-Long, O’Brien, Sheila F.
Publicado 2022

Sensitivity of the Elecsys Nucleocapsid Assay for the Detection of Preceding SARS-CoV-2 Infections

por Grunau, Brian, Tom, Janessa, Asamoah-Boaheng, Michael, O’Brien, Sheila F, Drews, Steven J, Sediqi, Sadaf, Lavoie, Pascal M, Barakauskas, Vilte, Goldfarb, David M
Publicado 2022

Hepatitis B Blood Donor Screening Data: An Under-Recognized Resource for Canadian Public Health Surveillance

por O’Brien, Sheila F., Reedman, Cassandra N., Osiowy, Carla, Bolotin, Shelly, Yi, Qi-Long, Lourenço, Lillian, Lewin, Antoine, Binka, Mawuena, Caffrey, Niamh, Drews, Steven J.
Publicado 2023

Estimating SARS-CoV-2 Seroprevalence in Canadian Blood Donors, April 2020 to March 2021: Improving Accuracy with Multiple Assays

por Tuite, Ashleigh R., Fisman, David, Abe, Kento T., Rathod, Bhavisha, Pasculescu, Adrian, Colwill, Karen, Gingras, Anne-Claude, Yi, Qi-Long, O’Brien, Sheila F., Drews, Steven J.
Publicado 2022

A Qualitative Comparison of the Abbott SARS-CoV-2 IgG II Quant Assay against Commonly Used Canadian SARS-CoV-2 Enzyme Immunoassays in Blood Donor Retention Specimens, April 2020 to...

por Abe, Kento T., Rathod, Bhavisha, Colwill, Karen, Gingras, Anne-Claude, Tuite, Ashleigh, Robbins, Ninette F., Orjuela, Guillermo, Jenkins, Craig, Conrod, Valerie, Yi, Qi-Long, O’Brien, Sheila F., Drews, Steven J.
Publicado 2022

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence: Navigating the absence of a gold standard

por Saeed, Sahar, O’Brien, Sheila F., Abe, Kento, Yi, Qi-Long, Rathod, Bhavisha, Wang, Jenny, Fazel-Zarandi, Mahya, Tuite, Ashleigh, Fisman, David, Wood, Heidi, Colwill, Karen, Gingras, Anne-Claude, Drews, Steven J.
Publicado 2021

Diminished Neutralization Capacity of SARS-CoV-2 Omicron BA.1 in Donor Plasma Collected from January to March 2021

por Lin, Yi-Chan J., Evans, David H., Robbins, Ninette F., Orjuela, Guillermo, Abe, Kento T., Rathod, Bhavisha, Colwill, Karen, Gingras, Anne-Claude, Tuite, Ashleigh, Yi, Qi-Long, O’Brien, Sheila F., Drews, Steven J.
Publicado 2023

Cross-Canada Variability in Blood Donor SARS-CoV-2 Seroprevalence by Social Determinants of Health

por O’Brien, Sheila F., Caffrey, Niamh, Yi, Qi-Long, Bolotin, Shelly, Janjua, Naveed Z., Binka, Mawuena, Thanh, Caroline Quach, Stein, Derek R., Lang, Amanda, Colquhoun, Amy, Pambrun, Chantale, Reedman, Cassandra N., Drews, Steven J.
Publicado 2023

Determining the Optimal SARS-CoV-2 mRNA Vaccine Dosing Interval for Maximum Immunogenicity

por Asamoah-Boaheng, Michael, Goldfarb, David, Prusinkiewicz, Martin A, Golding, Liam, Karim, Mohammad E, Barakauskas, Vilte, Wall, Nechelle, Jassem, Agatha N, Marquez, Ana Citlali, MacDonald, Chris, O’Brien, Sheila F, Lavoie, Pascal, Grunau, Brian
Publicado 2023

Comparative 6-Month Wild-Type and Delta-Variant Antibody Levels and Surrogate Neutralization for Adults Vaccinated with BNT162b2 versus mRNA-1273

por Grunau, Brian, Golding, Liam, Prusinkiewicz, Martin A., Asamoah-Boaheng, Michael, Armour, Richard, Marquez, Ana Citlali, Jassem, Agatha N., Barakauskas, Vilte, O’Brien, Sheila F., Drews, Steven J., Haig, Scott, Lavoie, Pascal M., Goldfarb, David M.
Publicado 2022

A Prospective Observational Cohort Comparison of SARS-CoV-2 Seroprevalence Between Paramedics and Matched Blood Donors in Canada During the COVID-19 Pandemic

por Grunau, Brian, O’Brien, Sheila F., Kirkham, Tracy L., Helmer, Jennie, Demers, Paul A., Asamoah-Boaheng, Michael, Drews, Steven J., Karim, Mohammad Ehsanul, Srigley, Jocelyn A., Sediqi, Sadaf, O’Neill, David, Drennan, Ian R., Goldfarb, David M.
Publicado 2022

Utilization of the Abbott SARS-CoV-2 IgG II Quant Assay To Identify High-Titer Anti-SARS-CoV-2 Neutralizing Plasma against Wild-Type and Variant SARS-CoV-2 Viruses

por Lin, Yi-Chan J., Evans, David H., Robbins, Ninette F., Orjuela, Guillermo, Hu, Queenie, Samson, Reuben, Abe, Kento T., Rathod, Bhavisha, Colwill, Karen, Gingras, Anne-Claude, Tuite, Ashleigh, Yi, Qi-Long, O’Brien, Sheila F., Drews, Steven J.
Publicado 2022